November 10, 2015
Boston, MA
The post-grant opposition procedure at the European Patent Office (EPO) is a powerful tool. More than two-thirds of European patents that are opposed end up being either narrowed in scope or revoked entirely. With applicants from the United States receiving the most European patent grants, understanding how the EPO opposition procedure works, from both offensive and defensive perspectives, will form a key part of any U.S. practitioner’s international patent strategy.
Developing consistent strategies and knowing how to take advantage of both the similarities and the differences between EPO oppositions and U.S. post-grant challenges can give rise to time and cost efficiencies, while ensuring consistent and optimized strategies in each jurisdiction. Please join Finnegan’s European Patent Attorneys as they discuss the following topics and provide practical tips and insights:
Due to space limitations, please register early.
Hazel Ford, Ph.D.
Leslie A. McDonell
Tuesday, November 10, 2015
2:30 - 3:00 p.m. – Registration
3:00 - 5:30 p.m. – Seminar
5:30 - 6:30 p.m. – Reception
Finnegan
Two Seaport Lane
Boston, MA 02210
Webinar
Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe
November 19, 2026
Webinar
Webinar
2026 Inventive Step in Europe and the US: Comparing the UPC, EPO and National Approaches
October 14, 2026
Webinar
Conference
2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada
October 14-16, 2026
New York
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.